Navigation Links
Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
Date:2/25/2008

Study Outcomes Include Increased Productivity and End-User Satisfaction,

Enhanced Workflow and Quality of Care Improvements

ORLANDO, Fla., Feb. 25 /PRNewswire-FirstCall/ -- Today, at the Healthcare Information and Management Systems Society (HIMSS) 2008 Annual Conference and Exhibition in Orlando, Siemens (http://www.usa.siemens.com/healthcareit) and Alegent Health, the largest not-for-profit, faith-based healthcare system in Nebraska and southwestern Iowa, announced the results of a clinician usability study that was recently deployed at Alegent Health's Lakeside Hospital in Omaha, Neb.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

The results from the study revealed: significant increases in end-user satisfaction; quality of care improvements as a result of increased ability to document at the point of care; increased clinician productivity due to increased mobility; reduced device performance issues and improved workflow; and projected cost savings.

The study examined the usability of the Motion Computing(R) C5 MCA (Mobile Clinical Assistant) with Siemens Soarian(R) and Siemens Med Administration Check(TM) (MAK). The Motion(TM) C5 MCA is a tablet PC created by Motion Computing with support from Intel Corporation that includes features such as integrated barcode and RFID readers for patient identification and/or electronic medication administration, and built-in WiFi and Bluetooth for wireless connectivity. Siemens actively contributed input to the development of the Motion C5 MCA to enhance the clinician end-user experience for those who are also utilizing Siemens solutions.

During the study, clinicians accessed Soarian, Siemens next-generation, workflow-engineered healthcare information system, and Siemens MAK, which automatically validat
'/>"/>

SOURCE Siemens Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...RNewswire/ -- Axentis Pharma AG has,initiated a cl...lerability,of a new therapeutic formulation for th...c fibrosis patients. The new formulation allows an...ectly to the site of,infection. The forthcoming tr... doses of the new drug. Initial results are expect...
(Date:9/4/2008)...cation for Targeted Therapies That En...TON BEACH, Calif., and AMSTERDAM, Netherlands, Sep...lecular cancer diagnostics,today announced the la...,allows physicians to quantitatively determine the...ER), progesterone receptor (PR) and Human Epiderma...
(Date:9/3/2008)...g Children Studied. Wrong,Conclusions Reached., N...ters for Disease,Control and Prevention (CDC) stud...he MMR vaccine and autism. The National Autism Ass...pel the growing public concern over a,vaccine-auti...ing design,and methodology., For years, parents h...
(Date:9/3/2008)...chronically infected Hepatitis C,patients strongly... in 2008, - Study is the first to show a statist...effect of therapeutic Hepatitis C vaccination, -...a second generation, vaccine formulated with Inte... activation, VIENNA, Austr...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2CDC Misses Target With Flawed MMR/Autism Study 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4New approach builds better proteins inside a computer 863 1New approach builds better proteins inside a computer 863 2New approach builds better proteins inside a computer 863 3New approach builds better proteins inside a computer 863 4Changing the global dietary environment 861 1Changing the global dietary environment 861 2Deadlines for 2007 National Soybean Rust Symposium fast approaching 859 1Deadlines for 2007 National Soybean Rust Symposium fast approaching 859 2Tolerance to inhalants may be caused by changes in gene expression 857 1Tolerance to inhalants may be caused by changes in gene expression 857 2
...7 - EPIX,Pharmaceuticals, Inc. (NASDAQ: EPIX) toda...X-00023, a novel long-acting 5-HT1A agonist,was f...l New,Clinical Drug Evaluation Unit (NCDEU) Meetin... by the National Institutes of,Health and the Amer...presentation highlighted data from a randomized,d...
... Prolexys,Pharmaceuticals and announced today a pu...ve small molecule anti-tumor agent,erastin. Prole...omics technology to understand the mechanism of ac...he June 14, 2007 issue,of the journal Nature revea...endent anion channels (VDACs) -- a novel target fo...
Other Medicine Technology:EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...ly hurt in a farm accident, claimed a chance for s... The 16 year old teenage boy had suffered grave in... helicopter. Insp Roger McConnell, who accompanied...n't want to take all the credit, because the fire ...
...arize and improve collaboration regarding the emer...se, more specifically bird flu//, a training progr...scenario involving transfer of a suspected case of...er was simulated. The Baptist Hospital and the Qu...
...eat promise for new treatments for many conditions... types of adult tissue//. But the human embryo ste... scientists believe the human testicle may provide...or stem cell research. A German team has describ...
...g sensitive to noise, and do not like it much! Acc...noisy surroundings// may face an increased risk of... revealed that the chances of urban middle-aged ad...and amidst a lot of din, stood a 46 percent chance...
Other Medicine News:Health News:Human Testicular Cells Would Help In Stem Cell Research 2
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
Medicine Products: